What one share of Benitec Biopharma holds
Benitec Biopharma Inc. (“Benitec” or the “Company” or in the first person, “we” or “our”) is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines with headquarters in Hayward, California.
Benitec Biopharma’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.98 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.36 |
| Cash and investments | $5.23 |
| Book value | $5.14 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | $51.77 | $8.02 | $87.03 | — | $329.26 |
| 2020 | $1.70 | −$137.74 | $1.58 | −$127.02 | — | $157.03 |
| 2021 | $0.23 | −$54.94 | $0.87 | −$51.66 | — | $41.63 |
| 2022 | $0.15 | −$37.88 | $0.03 | −$33.10 | — | $6.00 |
| 2023 | $0.05 | −$14.12 | $0.00 | −$13.00 | — | $0.12 |
| 2024 | $0.00 | −$1.22 | $0.01 | −$1.07 | — | $4.68 |
| 2025 | — | −$1.05 | $0.00 | −$0.65 | — | $3.71 |
| 2026 | — | −$0.98 | $0.00 | −$0.36 | — | $5.14 |
Common questions about Benitec Biopharma
How much does one share of Benitec Biopharma earn?
Over its latest fiscal year, Benitec Biopharma lost $0.98 for each share.
Does Benitec Biopharma pay a dividend?
Benitec Biopharma didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is Benitec Biopharma’s book value per share?
Benitec Biopharma’s book value is $5.14 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Benitec Biopharma have?
Each share of Benitec Biopharma has $5.23 of cash and investments, as of June 30, 2026.
What is Benitec Biopharma’s free cash flow per share?
−$0.36 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
Has Benitec Biopharma bought back shares?
Benitec Biopharma’s share count rose about 92281% from 2019 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.